Top Page
Victrex
(LSE:VCT)
Victrex (VCT) vs. iShares MSCI United Kingdom ETF (EWC)
Victrex Business Overview & Revenue Model
Victrex Earnings Call Summary
Victrex Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 292.70M | 296.40M | 296.20M | 307.00M | 341.00M | 306.30M |
| Gross Profit | 128.60M | 132.60M | 134.30M | 162.60M | 174.70M | 157.00M |
| EBITDA | 68.60M | 61.10M | 69.70M | 96.00M | 120.80M | 115.50M |
| Net Income | 27.80M | 27.80M | 17.20M | 61.70M | 76.20M | 73.20M |
Balance Sheet | ||||||
| Total Assets | 566.90M | 566.90M | 592.00M | 626.60M | 641.60M | 615.30M |
| Cash, Cash Equivalents and Short-Term Investments | 24.20M | 24.20M | 29.30M | 33.50M | 68.80M | 112.40M |
| Total Debt | 49.00M | 49.00M | 50.40M | 50.20M | 32.10M | 15.90M |
| Total Liabilities | 135.70M | 135.70M | 130.40M | 125.60M | 151.00M | 103.60M |
| Stockholders Equity | 433.50M | 433.50M | 461.00M | 499.00M | 488.80M | 509.20M |
Cash Flow | ||||||
| Free Cash Flow | 48.90M | 49.30M | 51.40M | 2.30M | 34.50M | 85.20M |
| Operating Cash Flow | 70.70M | 71.10M | 84.00M | 40.80M | 80.00M | 127.10M |
| Investing Cash Flow | -21.80M | -21.80M | -35.40M | -32.30M | -16.20M | -83.20M |
| Financing Cash Flow | -53.70M | -54.60M | -51.90M | -32.80M | -82.40M | -41.70M |
Victrex Technical Analysis
Victrex Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
70 Outperform | £610.90M | 21.96 | 6.22% | 9.48% | 0.58% | 61.58% | |
65 Neutral | £3.86B | 27.59 | 6.17% | 3.45% | 2.36% | -13.99% | |
64 Neutral | £988.73M | -17.33 | 3.37% | 1.34% | -11.78% | -92.61% | |
63 Neutral | £276.99M | 30.00 | 3.48% | 2.44% | -4.71% | 86.21% | |
62 Neutral | £200.03M | 284.72 | 0.60% | 2.00% | 15.56% | -92.94% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
51 Neutral | £103.86M | -1.26 | -7.26% | ― | -4.41% | 2.29% |
Victrex Corporate Events
Victrex plc has confirmed that as of 31 December 2025 its issued share capital consists of 87,071,124 ordinary 1p shares, each carrying one vote, with no shares held in treasury. This brings the total number of voting rights in the company to 87,071,124, a figure that shareholders should use as the denominator when assessing whether they are required to disclose any holdings or changes in their interest under UK transparency rules.
The most recent analyst rating on (GB:VCT) stock is a Buy with a £714.00 price target. To see the full list of analyst forecasts on Victrex stock, see the GB:VCT Stock Forecast page.
Victrex plc has published its Annual Report & Accounts for the financial year ended 30 September 2025, making the document available on its corporate website and through the UK’s National Storage Mechanism. The release underscores the company’s continued focus on high-performance polymer solutions across key industrial and healthcare markets, giving investors and other stakeholders a consolidated view of its latest financial performance and strategic progress in advancing sustainable, value-adding materials.
The most recent analyst rating on (GB:VCT) stock is a Buy with a £714.00 price target. To see the full list of analyst forecasts on Victrex stock, see the GB:VCT Stock Forecast page.
Victrex plc has corrected a previous regulatory announcement to clarify that Chief Financial Officer Ian Melling purchased 3,500 ordinary shares in the company on 17 December 2025, not 18 December as originally stated, at a price of £6.43 per share on the London Stock Exchange. The transaction, disclosed under UK Market Abuse Regulation as an initial notification, underscores management’s direct equity exposure and alignment with shareholders, while the swift correction aims to maintain accurate market disclosure and regulatory compliance.
The most recent analyst rating on (GB:VCT) stock is a Buy with a £714.00 price target. To see the full list of analyst forecasts on Victrex stock, see the GB:VCT Stock Forecast page.
Victrex PLC announced that Ian Melling, the company’s Chief Financial Officer, exercised share options granted under the company’s incentive plans. The transaction highlights ongoing incentives for senior leadership and reflects the company’s commitment to aligning leadership rewards with its long-term growth strategy. The exercise of shares and retention of a portion underline confidence in the company’s performance and future, reinforcing its position as a leading supplier of advanced polymer solutions.
The most recent analyst rating on (GB:VCT) stock is a Buy with a £714.00 price target. To see the full list of analyst forecasts on Victrex stock, see the GB:VCT Stock Forecast page.
Victrex PLC has announced a share purchase by its CFO, Ian Melling, who acquired 3,500 ordinary shares in the company at £6.43 per share. This transaction highlights confidence in the company’s growth and performance, underscoring its leadership’s commitment to its future corporate direction and stakeholder interests.
The most recent analyst rating on (GB:VCT) stock is a Buy with a £714.00 price target. To see the full list of analyst forecasts on Victrex stock, see the GB:VCT Stock Forecast page.
Victrex plc announced that CEO Jakob Sigurdsson exercised share options under the company’s Long Term Incentive and Deferred Bonus Plans. This transaction, involving 29,297 ordinary shares, reflects executive participation in the company’s equity, potentially signaling confidence in Victrex’s strategic direction and market positioning. The exercise and partial sale of shares occurred on the London Stock Exchange, highlighting ongoing executive engagement with the company’s financial strategies.
The most recent analyst rating on (GB:VCT) stock is a Buy with a £714.00 price target. To see the full list of analyst forecasts on Victrex stock, see the GB:VCT Stock Forecast page.
Victrex plc announced the grant of share option awards to its Executive Directors, Jakob Sigurdsson and Ian Melling, under the company’s 2017 Deferred Bonus Plan and 2019 Long Term Incentive Plan. These awards, which are part of the company’s compensation strategy, are designed to align the interests of the executives with the company’s long-term performance goals, potentially impacting the company’s operational focus and stakeholder value.
The most recent analyst rating on (GB:VCT) stock is a Hold with a £700.00 price target. To see the full list of analyst forecasts on Victrex stock, see the GB:VCT Stock Forecast page.
Victrex plc announced that Dr. James Routh, who will become the CEO on January 1, 2026, has purchased 4,520 ordinary shares of the company. This voluntary disclosure highlights Dr. Routh’s commitment to the company ahead of his official start date, potentially signaling confidence in the company’s future and impacting stakeholders positively.
The most recent analyst rating on (GB:VCT) stock is a Hold with a £780.00 price target. To see the full list of analyst forecasts on Victrex stock, see the GB:VCT Stock Forecast page.
Victrex plc has announced an updated financial calendar following its preliminary results release. Key dates include the ex-dividend date on January 29, 2026, the AGM on February 6, 2026, and the final dividend payment on February 27, 2026. This announcement provides clarity on the company’s financial schedule, which is crucial for shareholders and stakeholders in planning their engagements and expectations.
The most recent analyst rating on (GB:VCT) stock is a Hold with a £780.00 price target. To see the full list of analyst forecasts on Victrex stock, see the GB:VCT Stock Forecast page.
Victrex reported a 12% increase in sales volume for FY 2025, driven by Value Added Resellers and the Energy & Industrial sectors, although revenue growth was modest at 1% due to an adverse sales mix and currency effects. The company is implementing a Profit Improvement Plan targeting £10 million in savings by FY 2027, alongside a broader review of operations to enhance efficiency, while maintaining dividends and adjusting its capital allocation policy to balance stakeholder interests.
The most recent analyst rating on (GB:VCT) stock is a Hold with a £6.60 price target. To see the full list of analyst forecasts on Victrex stock, see the GB:VCT Stock Forecast page.
Victrex PLC, a company listed on the stock market, announced that as of November 28, 2025, its issued share capital consists of 87,052,107 ordinary shares, each carrying one vote. This update is in line with the FCA’s Disclosure Guidance and Transparency Rules. The total number of voting rights is 87,052,107, which shareholders can use as a denominator to calculate their interest in the company. This announcement provides clarity on the company’s capital structure, ensuring transparency for stakeholders and aiding in compliance with regulatory requirements.
The most recent analyst rating on (GB:VCT) stock is a Hold with a £6.60 price target. To see the full list of analyst forecasts on Victrex stock, see the GB:VCT Stock Forecast page.
Victrex Plc has applied for a block listing of 310,000 ordinary shares on the London Stock Exchange, reserved for future share option exercises under its 2019 Long Term Incentive Plan. This move is expected to enhance the company’s financial flexibility and align with its strategic goals, potentially impacting its market positioning and shareholder value.
The most recent analyst rating on (GB:VCT) stock is a Hold with a £6.60 price target. To see the full list of analyst forecasts on Victrex stock, see the GB:VCT Stock Forecast page.
Victrex PLC announced that as of 31 October 2025, its issued share capital comprises 87,052,107 ordinary shares, each with one vote, and no shares are held in treasury. This update provides shareholders with the necessary information to calculate their interests in the company, which is crucial for maintaining transparency and compliance with regulatory requirements.
The most recent analyst rating on (GB:VCT) stock is a Buy with a £9.40 price target. To see the full list of analyst forecasts on Victrex stock, see the GB:VCT Stock Forecast page.
Victrex plc has announced that Dr. James Routh will assume the role of Chief Executive Officer starting January 1, 2026, succeeding Jakob Sigurdsson. This transition is part of a planned succession, with Sigurdsson remaining on the board until the company’s Annual General Meeting in February 2026 to ensure a smooth handover. The announcement is significant for Victrex as it continues to strengthen its leadership team, which is crucial for maintaining its position as a leader in the high-performance polymer solutions industry.
The most recent analyst rating on (GB:VCT) stock is a Buy with a £9.40 price target. To see the full list of analyst forecasts on Victrex stock, see the GB:VCT Stock Forecast page.